GILMELISIB
UNII B9ZBD8SQ96

Substance Identification & Data

This profile provides standardized clinical and technical data for Gilmelisib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B9ZBD8SQ96.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1845777-61-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B9ZBD8SQ96

CAS Registry Number

1845777-61-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GILMELISIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H23ClFN5O5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BXKBZQAZYOZHJY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C188554

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

118612873

Unique identification number in the NCBI database of chemical substances.

INN ID

11989

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O=c1n2c(ccc(c2)-c3cc(NS(=O)(=O)c4c(Cl)cc(F)cc4)c(OC)nc3)ncc1OCCN(C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gilmelisib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.